Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrophysiological measurement of ACC function in schizophrenic patients treated with Seroquel or Fluanxol
2007-004528-19Phase 4Active
- Sponsor
- University of Wuerzburg
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of quetiapine and flupentixol in schizophrenia (2 arms), sponsored by University of Wuerzburg. Primary endpoint: Anterior cingulate cortex activation (ERN/Ne amplitude). Started Nov 2007; status: active.
02
Drugs
quetiapineflupentixol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-004528-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004528-19.